Patent directory · USPTO A61K / A61P
Patents matching “CytomX Therapeutics, Inc.”
62 pharma patents match "CytomX Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 62 pharmaceutical patents matching "CytomX Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11046759
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
granted -
US 11035859
Compositions and methods for detecting protease activity in biological systems
granted -
US 11028126
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted -
US 10875913
Methods of treatment using activatable anti-EGFR antibodies
granted -
US 10800850
Therapeutic antibodies
granted -
US 10745481
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
granted -
US 10709799
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
granted -
US 10669337
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same
granted -
US 10669339
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
granted -
US 10611845
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
granted -
US 10568977
Antibodies that bind activatable antibodies and methods of use thereof
granted -
US 10533053
Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor
granted -
US 10513549
Cleavage-activatable interferon-alpha proprotein
granted -
US 10513558
Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof
granted -
US 10336824
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
granted -
US 10301380
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
granted -
US 10261083
Compositions and methods for detecting protease activity in biological systems
granted -
US 10233244
Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof
granted -
US 10179817
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
granted -
US 10138272
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted -
US 10118961
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
granted -
US 10059762
Anti-EGFR activatable antibodies
granted -
US 9889211
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
granted -
US 9737623
Antibodies that bind activatable antibodies and methods of use thereof
granted